Published in Antimicrob Agents Chemother on December 11, 2006
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.22
Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality. Eur J Clin Microbiol Infect Dis (2013) 1.07
Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care (2015) 0.85
Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients. Eur J Clin Microbiol Infect Dis (2008) 0.84
Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation. Infect Control Hosp Epidemiol (2012) 0.80
Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa. Antimicrob Agents Chemother (2008) 0.79
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis (2014) 0.78
Differential Role of Two-Component Regulatory Systems (phoPQ and pmrAB) in Polymyxin B Susceptibility of Pseudomonas aeruginosa. Adv Microbiol (2012) 0.77
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol (2003) 18.01
Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol (2005) 17.45
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis (2002) 6.76
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med (1998) 4.48
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis (2003) 4.09
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis (2003) 3.20
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother (1999) 3.16
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother (2006) 3.09
Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis (2002) 2.99
Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother (2003) 2.68
National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother (2004) 2.40
Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis (2004) 1.89
Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis (1999) 1.83
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis (2003) 1.67
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect (2006) 1.61
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am J Med (2006) 1.47
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. J Hosp Infect (2004) 1.33
Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol (2003) 1.30
Impact of severity of illness bias and control group misclassification bias in case-control studies of antimicrobial-resistant organisms. Infect Control Hosp Epidemiol (2005) 1.27
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology. Emerg Infect Dis (2002) 1.12
Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control (1999) 1.10
Nosocomial infections caused by multiresistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol (1999) 1.10
Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis (2002) 1.05
Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States. J Chemother (2004) 0.88
The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies. Infect Control Hosp Epidemiol (2006) 0.86
Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment. Clin Perform Qual Health Care (2000) 0.83
Definition of a pressure ulcer. Adv Wound Care (1995) 0.77
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm (2009) 7.43
Screening for intimate partner violence in health care settings: a randomized trial. JAMA (2009) 4.80
A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis (2007) 3.51
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis (2007) 3.30
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother (2008) 3.09
The use and interpretation of quasi-experimental studies in medical informatics. J Am Med Inform Assoc (2005) 2.75
Vancomycin: we can't get there from here. Clin Infect Dis (2011) 2.53
Approaches to screening for intimate partner violence in health care settings: a randomized trial. JAMA (2006) 2.50
Summer Peaks in the Incidences of Gram-Negative Bacterial Infection Among Hospitalized Patients. Infect Control Hosp Epidemiol (2008) 2.50
Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect Control Hosp Epidemiol (2008) 2.24
Effects of partner notification on reducing gonorrhea incidence rate. Sex Transm Dis (2007) 2.07
Variability in institutional review board assessment of minimal-risk research. Acad Emerg Med (2002) 1.99
Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis (2007) 1.98
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother (2007) 1.91
Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ (2005) 1.89
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol (2011) 1.83
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis (2011) 1.83
An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care (2005) 1.76
Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol (2005) 1.74
Bacterial contamination of health care workers' white coats. Am J Infect Control (2008) 1.71
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis (2005) 1.68
Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis (2007) 1.66
Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol (2006) 1.54
Quality of hospice care for individuals with dementia. J Am Geriatr Soc (2013) 1.53
Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med (2006) 1.53
Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob Agents Chemother (2010) 1.52
Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health (2006) 1.51
Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2006) 1.50
Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol (2010) 1.47
Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol (2014) 1.45
Emergency care of urban women with sexually transmitted infections: time to address deficiencies. Sex Transm Dis (2009) 1.42
Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc (2006) 1.40
Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008. Emerg Infect Dis (2011) 1.39
Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother (2010) 1.39
Black women's health: the effect of perceived racism and intimate partner violence. Violence Against Women (2006) 1.39
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis (2006) 1.34
Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Arch Intern Med (2008) 1.30
Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine (2011) 1.30
Impact of freezing on the future utility of archived surveillance culture specimens. Infect Control Hosp Epidemiol (2007) 1.29
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation. Antimicrob Agents Chemother (2004) 1.23
Intimate partner violence and comorbid mental health conditions among urban male patients. Ann Fam Med (2009) 1.22
Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points. Infect Control Hosp Epidemiol (2008) 1.21
Etiology of neonatal blood stream infections in Tbilisi, Republic of Georgia. Int J Infect Dis (2008) 1.17
Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition. Infect Control Hosp Epidemiol (2011) 1.16
Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PLoS One (2010) 1.15
Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control (2004) 1.12
Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect Dis (2008) 1.11
Methicillin-resistant Staphylococcus aureus infection and colonization among hospitalized prisoners. Infect Control Hosp Epidemiol (2007) 1.10
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother (2011) 1.09
Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents. Ann Pharmacother (2009) 1.09
Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities. Infect Control Hosp Epidemiol (2009) 1.08
Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes. Arch Intern Med (2003) 1.08
Value of performing active surveillance cultures on intensive care unit discharge for detection of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2007) 1.08
A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manage (2013) 1.07
Predictive ability of positive clinical culture results and International Classification of Diseases, Ninth Revision, to identify and classify noninvasive Staphylococcus aureus infections: a validation study. Infect Control Hosp Epidemiol (2010) 1.03
Changes in community socioeconomic status and racial distribution associated with gonorrhea rates: an analysis at the community level. Sex Transm Dis (2009) 1.03
Contribution of interfacility patient movement to overall methicillin-resistant Staphylococcus aureus prevalence levels. Infect Control Hosp Epidemiol (2011) 0.99
Childhood and adult abuse among women in primary health care: effects on mental health. J Interpers Violence (2003) 0.99
Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant gram-negative bacteria among intensive care unit patients. Infect Control Hosp Epidemiol (2007) 0.96
Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review. J Palliat Med (2013) 0.96
Issues in estimating the prevalence of intimate partner violence: assessing the impact of abuse status on participation bias. J Interpers Violence (2003) 0.95
The role of institutional epidemiologic weight in guiding infection surveillance and control in community and hospital populations. Infect Control Hosp Epidemiol (2006) 0.95
ASSERT: the effectiveness of a continuing medical education video on knowledge and attitudes about interpersonal violence. Acad Med (2003) 0.95
Pharmacy-managed program for providing education and discharge instructions for patients with heart failure. Am J Health Syst Pharm (2014) 0.95
Healthcare-associated infection and hospital readmission. Infect Control Hosp Epidemiol (2012) 0.95
Vancomycin-associated renal dysfunction: where are we now? Pharmacotherapy (2014) 0.94
Privacy in the pharmacy environment: analysis of observations from inside the pharmacy. J Am Pharm Assoc (2003) (2010) 0.94
Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol (2008) 0.93
Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting. Infect Control Hosp Epidemiol (2011) 0.92
Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens. Ann Pharmacother (2011) 0.91
Decline in perinatal HIV transmission in New York State (1997-2000). J Acquir Immune Defic Syndr (2004) 0.91
Stages of change as a correlate of mental health symptoms in abused, low-income African American women. J Clin Psychol (2006) 0.90
Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission. Infect Control Hosp Epidemiol (2010) 0.90
A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients. Infect Dis Ther (2015) 0.90
Serious mental illness and acute hospital readmission in diabetic patients. Am J Med Qual (2012) 0.90
Evaluation of a comprehensive AIDS education curriculum in Hungary--the role of good educators. J Adolesc (2002) 0.88
Risk factors for relapse of visceral leishmaniasis in Georgia. Trop Med Int Health (2010) 0.88
Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study. J Antimicrob Chemother (2009) 0.88